Literature DB >> 20218483

Severe snakebites in northern KwaZulu-Natal: treatment modalities and outcomes.

Darryl Wood1, Caroline Webb, Jenine DeMeyer.   

Abstract

OBJECTIVE: We aimed to study the outcomes of severe snakebites in patients admitted to Ngwelezana Hospital in north-eastern KwaZulu-Natal, the seasonal variations, and the effectiveness and complications of antivenom.
DESIGN: A prospective observational outcomes study was conducted over one year (1 June 2007 to 31 May 2008). The study group was from the north-eastern KwaZulu-Natal region of South Africa, with a population of approximately 3 million people, and included all patients bitten by snakes and admitted to the Ngwelezana Hospital Emergency Medicine Unit (EMU). Departmental practice guidelines were documented and followed. OUTCOME MEASURES: End-points for patient outcomes included transfer from the EMU to the ward, discharge home from the EMU, and follow-up of patients who required surgery or ICU care.
RESULTS: A total of 243 snakebite patients were recorded. The highest incidence was in the summer months; 46 (18.93%) patients experienced one or more severe complications; 29 (11.93%) patients received some form of definitive management in hospital; and 22 (9.05%) of the latter patients received antivenom. Antivenom was administered to more children than adults. Adverse reactions to antivenom were common: an allergic response occurred in 4 (15.4%) patients, and anaphylaxis in 6 (23.1%); the highest incidence occurred in the <10-year-old age group. No deaths were recorded.
CONCLUSIONS: Snakebites are common in the summer months in north eastern KwaZulu-Natal. Children are particularly vulnerable to snakebites and the effects of antivenom. Adverse reactions to antivenom are common. Severe snakebites that require antivenom should be managed in a hospital setting with advanced airway support. The syndromic approach to treatment is simple and effective.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20218483

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

1.  Surgical Considerations for Pediatric Snake Bites in Low- and Middle-Income Countries.

Authors:  Matthew C Hernandez; Michael Traynor; John L Bruce; Wanda Bekker; Grant L Laing; Johnathon M Aho; Victor Y Kong; Denise B Klinkner; Martin D Zielinski; Damian L Clarke
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

2.  Quantitative Characterization of the Hemorrhagic, Necrotic, Coagulation-Altering Properties and Edema-Forming Effects of Zebra Snake (Naja nigricincta nigricincta) Venom.

Authors:  Erick Kandiwa; Borden Mushonga; Alaster Samkange; Ezequiel Fabiano
Journal:  J Toxicol       Date:  2018-10-24

3.  Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial.

Authors:  Julien Potet; James Smith; Lachlan McIver
Journal:  PLoS Negl Trop Dis       Date:  2019-06-24

4.  'The medicine is not for sale': Practices of traditional healers in snakebite envenoming in Ghana.

Authors:  Jonathan Steinhorst; Leslie Mawuli Aglanu; Sofanne J Ravensbergen; Chrisantus Danaah Dari; Kabiru Mohammed Abass; Samuel Osei Mireku; Joseph Ken Adu Poku; Yeetey A K Enuameh; Jörg Blessmann; Robert A Harrison; John H Amuasi; Ymkje Stienstra
Journal:  PLoS Negl Trop Dis       Date:  2021-04-16

5.  Paediatric anaphylaxis in South Africa.

Authors:  Sa-Eeda Chippendale; Kirsten Reichmuth; Margitta Worm; Michael Levin
Journal:  World Allergy Organ J       Date:  2022-09-12       Impact factor: 5.516

Review 6.  Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.

Authors:  Rashmi Dixit; Jenny Herz; Richard Dalton; Robert Booy
Journal:  Vaccine       Date:  2016-01-20       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.